Subpart C—FDA Review

1. CFR
2. ›
3. Title 21
4. ›
5. Chapter I
6. ›
7. Part 1114
8. ›
9. Subpart C

Sections

Section numbering in the official eCFR can be non-consecutive. Omitted section numbers are not treated here as reserved unless the source explicitly labels them that way.

• 1114.25
  § 1114.25 Communication between FDA and applicants.
• 1114.27
  § 1114.27 Review procedure.
• 1114.29
  § 1114.29 FDA action on an application.
• 1114.31
  § 1114.31 Issuance of a marketing granted order.
• 1114.33
  § 1114.33 Issuance of a marketing denial order.
• 1114.35
  § 1114.35 Withdrawal of a marketing granted order.
• 1114.37
  § 1114.37 Temporary suspension of a marketing granted order.